Insulin Binds to Glucagon Forming a Complex that is Hyper-Antigenic and Inducing Complementary Antibodies Having an Idiotype-Antiidiotype Relationship

References

• Schloot NC, Roep BO, Wegmann D, Yu L, Chase HP, Wang T, Eisenbarlh GS. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia 1997; 40: 564–572
   PubMed Web of Science ®Google Scholar
• Snoorgaard O, Kjems LL, Roder ME, Hartling SG, Dinesen B, Binder C. Pro-insulin immunoreactivity in recent-onset IDDM: The significance of insulin antibodies and insulin autoantibodies. Diabetes Care. 1996; 19: 146–150
   PubMed Web of Science ®Google Scholar
• Sutherland EW., Cori CF, Haynes R, Olsen NS. Purification of the hyperglycemic glycogenolytic factor from insulin and from gastric mucosa. J. Biol. Chem. 1949; 180: 825
   PubMed Web of Science ®Google Scholar
• Bloch K. Blondes in Venetian Paintings, The Nine-Banded Armadillo, and Other Essays in Biochemistry. Yale, New Haven 1994; 78–83
   Google Scholar
• Chance RE, Root MA, Galloway JA. The immunogenicity of insulin preparations. Acta Endocrinologica 1976; 83: 185–195
   Google Scholar
• Foa P. P., Galansino G. Glucagon: Chemistry and Function in Health and Disease. Charles C. Thomas, Springfield, IL 1962; 6, 10,39,78
   Google Scholar
• Lee HM, Ellis RM, Bromer WW. Insulin-like activity of crystalline glucagon as measured with rat epididymal tat pad preparation. Proc Soc Exp Bio. Med. 1960; 104: 4
   PubMed Web of Science ®Google Scholar
• Root-Bernstein RS, Westall FC. Bovine pineal antireproduc-tive tripeptide binds to luteinizing hormone-releasing hormone: A model for peptide modulation by sequence specific peptide interactions?. Brain Res Bull. 1986; 17: 519–528
   PubMed Web of Science ®Google Scholar
• Ouchterlony O. Handbook of Immunodiffusion and Immunoelectrophoresis. Univ Mich Press, Ann Arbor, MI 1956
   Google Scholar
• Root-Bernstein RS, DeWitt SH. Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL. Genetica. 1995; 95: 133–156
   PubMed Web of Science ®Google Scholar
• Montenegro-Rodas F, Saman NA. Glucagonoma tumors and syndrome. Current Problems Cancer 1981; 6(6)1–54
   PubMedGoogle Scholar
• The Joys of Research, R. Yalow, W. In Shropshire. Smithsonian Press, Wash DC 1981; 109–110
   Google Scholar
• Fujinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus; mechanism for autoimmunity. Science 1985; 230: 1043–1045
   PubMed Web of Science ®Google Scholar
• Plote PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet. 1983; ii: 824–826
   Google Scholar
• Westall FC, Root-Bernstein RS. An explanation of prevention and suppression of experimental allergic encephalomyelitis. Mol Immunology 1983; 20: 169–77
   PubMed Web of Science ®Google Scholar
• Kilpatrick JM, Virella G. the role of circulating immune complexes in the pathogenesis of diabetes mellitus. Acta Diabetol Lat. 1982; 19: 107–39
   PubMedGoogle Scholar
• Srikanta S, Malaviya AN, Rajagopalan P, Bhuyan UN, Ahuja MM. Association of type I (insulin-dependent) diabetes mellitus, autoimmunity, antinuclear antibody, and membranopro-Hferative glomerulonephritis. Diabetes Care 1983; 6: 71–74
   PubMed Web of Science ®Google Scholar
• Amed E, Nityanand S, Mustafa A, Brismar K, Lefvert AK. Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications. Clin Exp Immunol. 1999; 115: 255–259
   PubMed Web of Science ®Google Scholar
• Triolo G, Giradina E, Rinaldi A, Bompiani GD. IgA-and insulin-containing (C3-fixing) circulating immune complexes in diabetes mellitus. Clin Immunol Immuiiopathol. 1984; 30: 169–177
   PubMed Web of Science ®Google Scholar
• von Schenck H., Grubb AO. Interference of immunoglobulins in two glucagon radioimmunoassays. Clin Chem. 1982; 28: 1103–1107
   PubMed Web of Science ®Google Scholar
• Weir GC, Knowlton SD, Martin DB. High molecular weight glucagon-like immunoreactivity in plasma. J Clin Endocrinol Metah. 1975; 40: 296–302
   PubMed Web of Science ®Google Scholar
• Krook A, Soos MA, Kumar S, Siddle K, O'Rahilly S. Functional activation of mutant human insulin receptor by monoclonal antibody. Lancet. 1996; 347: 1586–90
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Marshall S, Horikoshi H, Kolterman OG, Rubenstein AH, Olefsky JM. Anti-insulin receptor antibodies in insulin-dependent diabetics may arise as autoantiidiotypes. J Clin Endocrinol Metah. 1986; 63: 56–61
   PubMed Web of Science ®Google Scholar
• Dosch H, Cheung RK, Karges W, Pietropaolo M, Becker DJ. Persistent T cell anergy in human type 1 diabetes. J Immunol. 1999; 163: 6933–3940
   PubMed Web of Science ®Google Scholar
• Kukreza A, Maclaren NK. Autoimmunity and diabetes. J Clin Endocrinol Metah. 1999; 84: 4371–8
   PubMed Web of Science ®Google Scholar
• Amrani A, Verdaguer J, Thiessen S, Bou S, Santamaria P. IL-1 alpha, IL-1beta, and IFN-gamma mark beta cells for Fas-dependent destruction by diabetogenic CD4(+) T lymphocytes. J Clin Invest. 2000; 105: 459–468
   PubMed Web of Science ®Google Scholar
• Iwakoshi NN, Geriner DL, Rossini AA, Mordes JP. Diabetes prone BB rats are severely deficient in natural killer T cells. Autoimmunity 1999; 31: 1–14
   PubMed Web of Science ®Google Scholar
• Falcone M, Yeung B, Tucker L, Rodriguez E, Sarvetnick N. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in non-obese dabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus. J. Exp Med. 1999; 190: 963–972
   PubMed Web of Science ®Google Scholar
• Root-Bernstein RS, Westall FC. Complementarity between antigen and adjuvant in the induction of autoimmune diseases –a dual antigen hypothesis. Inferential Deductive Biol. 1986; 2: 1–37
   Google Scholar
• Root-Bernstein RS., Tauber Al. Self, non-self and the paradoxes of autoimmunity. Organism and the Development of Self. Kluwer, Boston 1991; 159–209
   Google Scholar
• Root-Bernstein RS, Yurochko F, Westall FC. Clinical suppression of experimental allergic encephalomyelitis by muramyl dipeptide 'adjuvant'. Brain Res Bull. 1986; 17: 473–476
   PubMed Web of Science ®Google Scholar
• Root-Bernstein RS, Westall FC. Serotonin binding sites. II. Muramyl dipeptides bind to serotonin binding sites on myelin basic protein., LHRH, MSH, and ACTH. Brain Res Bull. 1990; 25: 827–841
   PubMed Web of Science ®Google Scholar
• Takeuchi Y, Root-Bernstein RS, Shih JC. Peptide displacement of [3H] 5-hydroxytryptamine binding to cortical membranes. Brain Res Bull. 1990; 25: 817–820
   PubMed Web of Science ®Google Scholar